Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Versarien upbeat on recent company progress
(Sharecast News) - Advanced materials engineering group Versarien updated the market on its progress across several key sectors and markets on Friday, reporting a growing pipeline of opportunities, rising from £1.6m in October 2023 to £4.7m currently, with £1.6m in commercial opportunities and £3.1m in grants. The AIM-traded firm said it continued to focus on developing advanced materials, especially graphene, through manufacturing-light operations and technology licensing.
In the construction sector, the company said it had placed orders for equipment to enhance its in-house construction testing capabilities following a July fundraising.
The equipment would support the development of graphene-based products, such as Cementene.
Versarien said it had also signed its first significant 3D construction printing (3DCP) contract with Building For Humanity CIC for a project in Accrington, UK.
The company anticipated on-site activities to begin in 2025.
In addition, Versarien said it was working with Balfour Beatty on a 12-month project to develop graphene-enhanced 3DCP materials.
In the leisure sector, Versarien said it had seen growing demand for its Graphene-Wear inks, with sales to customers in Europe, South Korea, and South America.
The company said it was also working on improving its footwear compounds for Flux Footwear in the US to enable larger-scale production.
Versarien explained that its strategy also included expanding its technology licensing.
In March, it entered into a licensing agreement with Montana Química in Brazil, and was continuing to explore further partnerships globally.
Research and development activities remained a priority, the board said, with Versarien maintaining its collaboration with academic institutions and research centres to drive innovation in graphene and other advanced materials.
The company said it was planning to exhibit at key industry events, including UK Construction Week 2024 and Highways UK, as part of its efforts to expand its market presence and develop new talent through partnerships such as its recent collaboration with AccXel Construction School.
"I am delighted to report that Versarien is continuing to make significant strides in its commercial endeavours, building on our strong foundation of innovation and collaboration," said chief executive officer Dr Stephen Hodge.
"Over the past year, we have seen encouraging growth across all our key markets, particularly construction.
"We are achieving our milestones as laid out in our turnaround strategy with the disposal of AAC Cyroma and sale of our CVD graphene assets."
Dr Hodge said he was also "optimistic" that the company would be able to progress the sale of Total Carbide.
"Our strategic partnerships with large UK and global players are pushing us to the forefront of delivering sustainable, high-performance solutions enabled by our advanced materials and technologies.
"We are proud to be working with companies that share our vision for a cleaner, more efficient future, and we are seeing the fruits of these collaborations materialise in new development contracts."
At 1537 BST, shares in Versarien were down 0.92% at 0.05p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.